Company Filing History:
Years Active: 1998
Title: Edward James Little - Innovator in Immunomodulatory Pharmaceuticals
Introduction
Edward James Little is a distinguished inventor based in Swindon, GB. With a total of two patents to his name, he has made significant contributions to the field of pharmaceuticals, particularly in the development of medicinal compounds with immunomodulatory properties.
Latest Patents
His latest patents focus on the medicinal use of N-Phenyl-2-cyano-3-hydroxycrotonamide derivatives. This innovative work describes the compounds and their application as pharmaceuticals that can effectively treat rheumatic diseases, autoimmune diseases, and manage rejection reactions in organ transplant recipients. The detailed formula outlines various configurations of the derivatives, showcasing a broad range of potential applications in medical treatments.
Career Highlights
Edward is associated with Hoechst Aktiengesellschaft, a company renowned for its contributions to the pharmaceutical industry. His research and development efforts have paved the way for advancements in immunotherapy, impacting numerous patients' lives who suffer from complex medical conditions.
Collaborations
During his career, Edward has worked alongside esteemed colleagues such as Rudolf Schleyerbach and Robert R Bartlett. Their collaborative efforts highlight the importance of teamwork in the research and development of innovative technologies.
Conclusion
Edward James Little's work exemplifies the spirit of innovation within the pharmaceutical field. His patents not only advance scientific understanding but also hold the promise of providing critical therapies for patients across a range of health challenges. Through his continued efforts at Hoechst Aktiengesellschaft, he remains a key figure in the evolution of immunomodulatory treatments.